Penta Investment – A&D Pharma Deal Close To Completion

12.05.2017 By Cristina Rosca , Cristian Hostiuc

The deal whereby Czech private equity firm Penta Investment buys A&D Pharma, the largest group on Romania’s pharmaceutical market, is close to completion, as an agreement is due for signing by the end of the year, market sources say.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 25 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

Keywords:
acquisition
, penta
, a&d pharma
, talks

Please fill all required fields!

Your comment was successfully added!

Comments will appear only after the moderation.